BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 17034567)

  • 1. Long-term infliximab for severe hidradenitis suppurativa.
    Thielen AM; Barde C; Saurat JH
    Br J Dermatol; 2006 Nov; 155(5):1105-7. PubMed ID: 17034567
    [No Abstract]   [Full Text] [Related]  

  • 2. Severe hidradenitis suppurativa treated with infliximab infusion.
    Adams DR; Gordon KB; Devenyi AG; Ioffreda MD
    Arch Dermatol; 2003 Dec; 139(12):1540-2. PubMed ID: 14676068
    [No Abstract]   [Full Text] [Related]  

  • 3. Long-term efficacy of a single course of infliximab in hidradenitis suppurativa.
    Mekkes JR; Bos JD
    Br J Dermatol; 2008 Feb; 158(2):370-4. PubMed ID: 18047504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hidradenitis suppurativa responding to treatment with infliximab.
    Lasocki A; Sinclair R; Foley P; Saunders H
    Australas J Dermatol; 2010 Aug; 51(3):186-90. PubMed ID: 20695857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of hidradenitis suppurativa with infliximab in a patient with Crohn's disease.
    Rosi YL; Lowe L; Kang S
    J Dermatolog Treat; 2005 Feb; 16(1):58-61. PubMed ID: 15897171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Axillary hidradenitis suppurativa successfully treated with infliximab in a Crohn's disease patient.
    Katsanos KH; Christodoulou DK; Tsianos EV
    Am J Gastroenterol; 2002 Aug; 97(8):2155-6. PubMed ID: 12190206
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of severe hidradenitis suppurativa with infliximab in combination with surgical interventions.
    Van Rappard DC; Mekkes JR
    Br J Dermatol; 2012 Jul; 167(1):206-8. PubMed ID: 22229974
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of hidradenitis suppurativa with tumour necrosis factor-alpha inhibitors: An update on infliximab.
    Brunasso AM; Massone C
    Acta Derm Venereol; 2011 Jan; 91(1):70-1. PubMed ID: 21103830
    [No Abstract]   [Full Text] [Related]  

  • 9. Acne inversa treated with infliximab: different outcomes in 2 patients.
    Antonucci A; Negosanti M; Negosanti L; Iozzo I; Varotti C
    Acta Derm Venereol; 2008; 88(3):274-5. PubMed ID: 18480930
    [No Abstract]   [Full Text] [Related]  

  • 10. Paradoxical effect of infliximab in a patient with hidradenitis suppurativa.
    Gori A; Rossari S; Bruscino N; Tripo L
    Dermatol Ther; 2012; 25(4):376-8. PubMed ID: 22950564
    [No Abstract]   [Full Text] [Related]  

  • 11. Infliximab for the treatment of hidradenitis suppurativa.
    Fernández-Vozmediano JM; Armario-Hita JC
    Dermatology; 2007; 215(1):41-4. PubMed ID: 17587838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acne inversa successfully treated with infliximab.
    von Preussen AC; Flux K; Hartschuh W; Hartmann M
    Int J Dermatol; 2012 Aug; 51(8):1011-3. PubMed ID: 21470216
    [No Abstract]   [Full Text] [Related]  

  • 13. Variable response of hidradenitis suppurativa to infliximab in four patients.
    Usmani N; Clayton TH; Everett S; Goodfield MD
    Clin Exp Dermatol; 2007 Mar; 32(2):204-5. PubMed ID: 17342798
    [No Abstract]   [Full Text] [Related]  

  • 14. Long-term efficacy of infliximab in hidradenitis suppurativa.
    Paradela S; Rodríguez-Lojo R; Fernández-Torres R; Arévalo P; Fonseca E
    J Dermatolog Treat; 2012 Aug; 23(4):278-83. PubMed ID: 22482700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of hidradenitis suppurativa with infliximab.
    Torres T; Selores M
    An Bras Dermatol; 2010; 85(4):576. PubMed ID: 20944927
    [No Abstract]   [Full Text] [Related]  

  • 16. Infliximab for severe hidradenitis suppurativa: transient clinical efficacy in 7 consecutive patients.
    Fardet L; Dupuy A; Kerob D; Levy A; Allez M; Begon E; Bachelez H; Morel P; Lebbé C
    J Am Acad Dermatol; 2007 Apr; 56(4):624-8. PubMed ID: 17240478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amyloidosis secondary to hidradenitis suppurativa. Exceptional response to infliximab.
    Montes-Romero JA; Callejas-Rubio JL; Sánchez-Cano D; González-Martínez FJ; Navas-Parejo A; Ortego-Centeno N
    Eur J Intern Med; 2008 Oct; 19(6):e32-3. PubMed ID: 18848164
    [No Abstract]   [Full Text] [Related]  

  • 18. Four-weekly infliximab in the treatment of severe hidradenitis suppurativa.
    Moriarty B; Jiyad Z; Creamer D
    Br J Dermatol; 2014 Apr; 170(4):986-7. PubMed ID: 24641123
    [No Abstract]   [Full Text] [Related]  

  • 19. Hidradenitis suppurativa and concomitant pyoderma gangrenosum treated With infliximab.
    Groleau PF; Grossberg AL; Gaspari AA
    Cutis; 2015 Jun; 95(6):337-42. PubMed ID: 26125210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mooren's-type ulceration associated with severe hidradenitis suppurativa: a case report and literature review.
    Meskin SW; Carlson EM
    Ocul Immunol Inflamm; 2011 Oct; 19(5):340-2. PubMed ID: 21823931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.